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Toward a Better Understanding of...

Development of Diabetic Zebrafish Model
for Genetic Screening
Yixi Wang
Mentors: Christopher Emfinger and Colin Nichols
Neonatal diabetes is a rare subset of the disease diabetes and affects an estimated 1 in
250,000 births. As in other types of diabetes mellitus, the body is unable to effectively
control blood glucose levels due to a faulty insulin response. The ATP-sensitive potassium
(KATP) channel is instrumental in insulin response, and gain of function mutations in its
two subunits, kir6.2 and SUR1, are the primary cause of neonatal diabetes.
Previous studies have shown that the SUR1 subunit, which regulates channel
sensitivity, can be targeted with the drug sulfonylurea as a form of treatment for the
disease. However, required level of treatment and symptom severity of the studied cases
can vary widely. This variation in expression of the mutations can be caused by many
underlying factors, some of which may be mutations in other parts of the genome. A
possible method to isolate these modifiers is a forward genetic screen.
To do so, we made an inducible neonatal diabetes model. We chose to use zebrafish
as our model organism because of their similarities to humans and other practical
advantages. We created a kir6.2 gain of function construct and established lines of fish
that expressed the mutation. After testing, they have recapitulated several aspects of the
disease in humans. In addition, a few assays essential for the screening process have
been developed. With these tools, we will be able to identify individuals that deviate
significantly in expression of the disease and genotype them to find candidate genes that
modulate neonatal diabetes in humans as well. This will improve our understanding of
the disease and inform future treatment.
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